Literature DB >> 18508557

Protein tyrosine phosphatases in the JAK/STAT pathway.

Dan Xu1, Cheng-Kui Qu.   

Abstract

The Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway is crucial in controlling cellular activities in response to extracellular cytokines. Dysfunctions of the JAK/STAT pathway result in various hematopoietic and immune disorders. The central events in regulating this pathway are tyrosine phosphorylation and dephosphorylation of the signaling components, which are carried out by protein tyrosine kinases and protein tyrosine phosphatases (PTP), respectively. Here, we review recent advances in the regulatory roles of PTPs, in particular, SHP2 phosphatase, in the JAK/STAT signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18508557      PMCID: PMC2599796          DOI: 10.2741/3051

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  88 in total

1.  Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain.

Authors:  X Xu; Y L Sun; T Hoey
Journal:  Science       Date:  1996-08-09       Impact factor: 47.728

2.  Enhancement of antiproliferative activity of gamma interferon by the specific inhibition of tyrosine dephosphorylation of Stat1.

Authors:  K Shuai; J Liao; M M Song
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

3.  Insulin signaling in mice expressing reduced levels of Syp.

Authors:  J M Arrandale; A Gore-Willse; S Rocks; J M Ren; J Zhu; A Davis; J N Livingston; D U Rabin
Journal:  J Biol Chem       Date:  1996-08-30       Impact factor: 5.157

4.  Direct association with and dephosphorylation of Jak2 kinase by the SH2-domain-containing protein tyrosine phosphatase SHP-1.

Authors:  H Jiao; K Berrada; W Yang; M Tabrizi; L C Platanias; T Yi
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

Review 5.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

Authors:  J E Darnell; I M Kerr; G R Stark
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

6.  Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1.

Authors:  M David; H E Chen; S Goelz; A C Larner; B G Neel
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

7.  PTP1D is a positive regulator of the prolactin signal leading to beta-casein promoter activation.

Authors:  S Ali; Z Chen; J J Lebrun; W Vogel; A Kharitonenkov; P A Kelly; A Ullrich
Journal:  EMBO J       Date:  1996-01-02       Impact factor: 11.598

8.  Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions.

Authors:  K Shuai; C M Horvath; L H Huang; S A Qureshi; D Cowburn; J E Darnell
Journal:  Cell       Date:  1994-03-11       Impact factor: 41.582

9.  Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals.

Authors:  U Klingmüller; U Lorenz; L C Cantley; B G Neel; H F Lodish
Journal:  Cell       Date:  1995-03-10       Impact factor: 41.582

10.  Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-alpha and -gamma signal transduction pathways.

Authors:  M Müller; C Laxton; J Briscoe; C Schindler; T Improta; J E Darnell; G R Stark; I M Kerr
Journal:  EMBO J       Date:  1993-11       Impact factor: 11.598

View more
  116 in total

1.  Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90.

Authors:  Kamalika Moulick; James H Ahn; Hongliang Zong; Anna Rodina; Leandro Cerchietti; Erica M Gomes DaGama; Eloisi Caldas-Lopes; Kristin Beebe; Fabiana Perna; Katerina Hatzi; Ly P Vu; Xinyang Zhao; Danuta Zatorska; Tony Taldone; Peter Smith-Jones; Mary Alpaugh; Steven S Gross; Nagavarakishore Pillarsetty; Thomas Ku; Jason S Lewis; Steven M Larson; Ross Levine; Hediye Erdjument-Bromage; Monica L Guzman; Stephen D Nimer; Ari Melnick; Len Neckers; Gabriela Chiosis
Journal:  Nat Chem Biol       Date:  2011-09-25       Impact factor: 15.040

2.  Noonan syndrome: clinical aspects and molecular pathogenesis.

Authors:  M Tartaglia; G Zampino; B D Gelb
Journal:  Mol Syndromol       Date:  2010-01-15

Review 3.  LILRB receptor-mediated regulation of myeloid cell maturation and function.

Authors:  William van der Touw; Hui-Ming Chen; Ping-Ying Pan; Shu-Hsia Chen
Journal:  Cancer Immunol Immunother       Date:  2017-06-21       Impact factor: 6.968

4.  Mechanism of shortened bones in mucopolysaccharidosis VII.

Authors:  Jason A Metcalf; Yanming Zhang; Matthew J Hilton; Fanxin Long; Katherine P Ponder
Journal:  Mol Genet Metab       Date:  2009-03-25       Impact factor: 4.797

5.  Gain-of-function mutations in the gene encoding the tyrosine phosphatase SHP2 induce hydrocephalus in a catalytically dependent manner.

Authors:  Hong Zheng; Wen-Mei Yu; Ronald R Waclaw; Maria I Kontaridis; Benjamin G Neel; Cheng-Kui Qu
Journal:  Sci Signal       Date:  2018-03-20       Impact factor: 8.192

6.  E3 ubiquitin ligase NKLAM ubiquitinates STAT1 and positively regulates STAT1-mediated transcriptional activity.

Authors:  Donald W Lawrence; Jacki Kornbluth
Journal:  Cell Signal       Date:  2016-08-26       Impact factor: 4.315

7.  Trichomide A, a natural cyclodepsipeptide, exerts immunosuppressive activity against activated T lymphocytes by upregulating SHP2 activation to overcome contact dermatitis.

Authors:  Xingqi Wang; Aihua Zhang; Jian Gao; Wei Chen; Shiyu Wang; Xuefeng Wu; Yan Shen; Yuehai Ke; Zichun Hua; Renxiang Tan; Yang Sun; Qiang Xu
Journal:  J Invest Dermatol       Date:  2014-06-16       Impact factor: 8.551

8.  Small Molecule Inhibitor that Stabilizes the Autoinhibited Conformation of the Oncogenic Tyrosine Phosphatase SHP2.

Authors:  Xiaoqin Wu; Gang Xu; Xiaobo Li; Weiren Xu; Qianjin Li; Wei Liu; Karen A Kirby; Mignon L Loh; Jun Li; Stefan G Sarafianos; Cheng-Kui Qu
Journal:  J Med Chem       Date:  2018-12-05       Impact factor: 7.446

9.  High-resolution crystal structures of the D1 and D2 domains of protein tyrosine phosphatase epsilon for structure-based drug design.

Authors:  George T Lountos; Sreejith Raran-Kurussi; Bryan M Zhao; Beverly K Dyas; Terrence R Burke; Robert G Ulrich; David S Waugh
Journal:  Acta Crystallogr D Struct Biol       Date:  2018-10-02       Impact factor: 7.652

10.  Sunitinib induces apoptosis and growth arrest of medulloblastoma tumor cells by inhibiting STAT3 and AKT signaling pathways.

Authors:  Fan Yang; Veronica Jove; Hong Xin; Michael Hedvat; Timothy E Van Meter; Hua Yu
Journal:  Mol Cancer Res       Date:  2010-01-06       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.